StockData
Elevance Health, Inc. logo

Elevance Health, Inc. (ELV) operating KPIs

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$420.07−1.95 (-0.46%)

Close on Oct 30, 2026Market cap $91.10BP/E 18.7Yield –

Elevance Health aFS Fixed Maturity Securities — Amortized Cost ($M)

Quarterly figures from Elevance Health's filings and investor materials

QuarterlyAnnual
Latest, Q3 2026
28,078
Period ended Sep 30, 2026
Change on a year earlier
+2.8%
27,310 in Q3 2025
History
46 quarters
Since Q2 2015
Sources
3
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAFS Fixed Maturity Securities — Amortized Cost ($M)Year on yearSource
Q3 2026Sep 30, 202628,078+2.8%ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis) ↗
Q2 2026Jun 30, 202627,225+2.4%ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis) ↗
Q1 2026Mar 31, 202627,298+1.5%ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis) ↗
Q4 2025Dec 31, 202526,889-0.1%ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis) ↗
Q3 2025Sep 30, 202527,310-7.8%ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis) ↗
Q2 2025Jun 30, 202526,590-13.4%ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis) ↗
Q1 2025Mar 31, 202526,883-14.2%ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis) ↗
Q4 2024Dec 31, 202426,928-14.1%ELV 10-K (XBRL us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis) ↗
Q3 2024Sep 30, 202429,622-4.5%ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis) ↗
Q2 2024Jun 30, 202430,701-0.1%ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis) ↗
Q1 2024Mar 31, 202431,329+3.8%ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis) ↗
Q4 2023Dec 31, 202331,336+8.0%ELV 10-K (XBRL us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis) ↗
Q3 2023Sep 30, 202331,013+7.0%ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis) ↗
Q2 2023Jun 30, 202330,724+10.9%ELV 10-Q/A (XBRL us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis) ↗
Q1 2023Mar 31, 202330,188+11.9%ELV 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis) ↗
Q4 2022Dec 31, 202229,015+10.5%ELV 10-K (XBRL us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis) ↗

Cite this data

StockData. (2026). Elevance Health AFS Fixed Maturity Securities — Amortized Cost ($M), quarterly Q2 2015–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/inv_afs_debt_amortized_cost

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.